BREAKING THROUGH TO FUNDING CANCER RESEARCH CLINICAL TRIALS
Gateway for Cancer Research accelerates practice-changing clinical trials to cancer research by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.
Explore Gateway’s cutting-edge cancer research program
Learn more about Gateway for Cancer Research and our critical mission
Donate to cancer research today and help advance lifesaving cancer research
GATEWAY FOR CANCER RESEARCH STORIES
Read about the unwavering patients and the cancer researchers who are helping us put and end to cancer as we know it.
Patient Profile: Kent
Kent enrolled in a Gateway-funded cancer research trial to treat his acute myeloid leukemia. See what he and his doctor had to say about his experience in this trial.Watch Kent’s Story
9,000+ patients have been impacted by Gateway for Cancer Research funded clinical trials to date.READ MORE
Improving Health Equity Together: A Conversation with Maria Rubinstein, Sameek Roychowdhury, and Mary Lou SmithRead the Article
“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”
- Beth, lymphoma patient in a Gateway-funded trial
Why Give to Gateway
99 cents of every dollar donated to Gateway goes directly towards funding a cancer clinical trial.DONATE NOW
Gateway Supports European Organisation for Research and Treatment of Cancer GrantRead More
Did You Know?
190+ clinical trials have been funded worldwide by Gateway for Cancer Research since 1991.View Our Clinical Trials
LATEST CANCER RESEARCH
Gateway for Cancer Research only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen.
Trial Type: Lung Cancer
Identification of Predictive Biomarkers to Prevent Pneumonitis in Patients with Non-Small Cell Lung Cancer Who are Receiving Immunotherapy (Phase II)
Ajay Sheshadri, MD
The University of Texas MD Anderson Cancer Center
Trial Type: Pancreatic Cancer
Novel Use of Pepinemab in Combination with Nivolumab and FOLFIRINOX Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma (Phase Ib/II)
David Linehan, MD
University of Rochester
Fund One Day
It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial.
Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniverary, birthday, wedding, bar/bat mitzvah or graduation.